News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Sarepta Therapeutics, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
BioMidwest
3 Biotech Stocks That Exploded in 2017
Rick Duprey, writing for The Motley Fool, takes a look at three biotech stocks that have quadrupled this year.
December 5, 2017
·
2 min read
·
Mark Terry
Genetown
Sarepta Jumps Despite DMD Safety Issues in FDA Database
October 3, 2017
·
2 min read
Policy
Sarepta’s Exondys 51 Saga Continues as More Details About FDA’s Criticism Uncovered
August 22, 2017
·
3 min read
Policy
FDA Docs Reveal CDER Chief Skirted Procedures Approving Sarepta’s Controversial Drug Eteplirsen
August 3, 2017
·
1 min read
Deals
New Sarepta CEO’s M&A Experience Sparks Sale Speculation
June 30, 2017
·
3 min read
Business
Sarepta Taps Allergan Alum as New CEO
June 29, 2017
·
2 min read
Policy
Journalist Sues FDA for Documents Related to Sarepta’s DMD Drug
May 26, 2017
·
4 min read
Genetown
Can Sarepta Continue To Live Up To The DMD Hype?
May 8, 2017
·
1 min read
Deals
Sarepta Tests Biotech’s CEO Vacuum Hypothesis
May 2, 2017
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 30, 2026
July 1, 2026
·
1 min read
Press Releases
Sarepta Announces FDA Acceptance of sNDAs for AMONDYS 45® and VYONDYS 53®
June 30, 2026
·
17 min read
Press Releases
Sarepta Therapeutics to Participate in Upcoming Investor Conferences
June 2, 2026
·
1 min read
Press Releases
Sarepta Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
May 14, 2026
·
1 min read
Press Releases
Sarepta Therapeutics Announces First Quarter 2026 Financial Results and Recent Corporate Developments
May 7, 2026
·
19 min read
Press Releases
Sarepta Therapeutics to Announce First Quarter 2026 Financial Results
April 23, 2026
·
1 min read
Press Releases
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 31, 2026
April 1, 2026
·
1 min read
Press Releases
Sarepta Announces First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
March 25, 2026
·
9 min read
Press Releases
Sarepta to Share First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
March 25, 2026
·
1 min read
Press Releases
Sarepta Provides Regulatory Update on AMONDYS 45® and VYONDYS 53®
March 19, 2026
·
15 min read
